Top 50 Biotechnology Startup Investors in Spain in July 2025
A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotechnology startups based in Spain. We rank investors based on the number of investments they made in Biotechnology companies from Spain. We update this investor list every month.Top 50 Biotechnology Startup Investors in Spain in July 2025
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more
Investment focus
- Biotechnology, Health Care, Software
- Funding Round, Seed, Grant
- Spain, United States, France
Portfolio highlights
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
- Ironchip — IRONCHIP means location-based security. We create cybersecurity solutions based on our exclusive unspoofable geolocation technology.
- Ideeea Therapeutics — Ideeea Therapeutics is a biotechnology start-up focused on advanced therapies (ATMPs).
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.
Show more
Investment focus
- Software, Biotechnology, E-Commerce
- Seed, Funding Round, Series A
- Spain, United States, United Kingdom
Portfolio highlights
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Scalestack — Scalestack AI brings all of your GTM data together, suggests prioritized actions and helps your reps to execute your sales plays. Unlock a new level of sales productivity and generate more pipeline.
- iPronics — Discover the power of lossless optical switches for low latency and flexible AI architectures. Increase density and reduce power consumption with our innovative technology.
SODENA is the main instrument of the Government of Navarre for the business development of the region. SODENA carries out its activities as a public limited company, with a majority direct shareholding of 65.42% by the Government of Navarre, and an indirect participation through Nafinco (14.58%). It also participates in the shareholding of GrupoCorporativo Empresarial Caja Navarra (20%), through TME 2001 CorpCan, S.L.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Debt Financing, Funding Round, Seed
- Spain, United Kingdom
Portfolio highlights
- Ubyko — Ubyko focuses on robotics and automation solutions for last-mile logistics in urban retail environments.
- Muxunav — Muxunav specialize in digital payment systems, they might be working on technologies like mobile payment solutions, online transaction systems, digital wallets, or even blockchain-based payment methods.
- Opportunity Health — Self-Applicable & Life-Saving | Fast, safe, and effective in emergencies | Contact us! | Opportunity Health
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Seed, Funding Round, Series A
- Spain, United States, United Kingdom
Portfolio highlights
- Orbidi — Orbidi is a digital marketing agency that provides SEO, website building, and Google Maps integration services for businesses.
- Ironchip — IRONCHIP means location-based security. We create cybersecurity solutions based on our exclusive unspoofable geolocation technology.
- The Channel Store — The Channel Store is a company specializing in the creation, distribution, and monetization of various types of channels, particularly in the FAST (Free Ad-Supported Streaming TV) and AVOD (Ad-Supported Video on Demand) sectors. It operates as a B2B service provider that manages content negotiations, integration, and monetization for its partners,enabling broadcasters, content owners, telcos, and streaming services to access and distribute a wide range of live and on-demand content globally.
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more
Investment focus
- Software, Health Care, E-Commerce
- Seed, Debt Financing, Pre-Seed
- Spain, United States, France
Portfolio highlights
- Mygocu — Mygocu is a platform for selling, organizing, and managing excursions and large-scale events.
- Supercubo — Supercubo is a Spanish startup based in Seville, founded with the goal of promoting healthy lifestyle habits by facilitating the creation of outdoor functional training centers through a scalable, low-risk, and cost-effective solution.Our project aims to both ease access for entrepreneurs and foster the growth of our community.The company wasfounded in December 2023 (starting operations in March 2024), and to date, the proof-of-concept for our three business lines has already been implemented and validated: • Own gyms • Franchisees • Third-party sales
- Modular DS — Modular DS enables WordPress professionals and businesses to save time managing their websites.
Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Seed, Funding Round, Series A
- Spain, France, Belgium
Portfolio highlights
- Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
- Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
- Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.
ICF Capital is a venture and growth capital management firm from ICF. ICF is a public financial institution founded in 1985 and owned by the Government of Catalonia. Our mission is to foster and improve access to funding for companies that operate in Catalonia in order to contribute to the growth of the region's economy while complementing theprivate financial sector. ICF provides funding to Catalan companies and entrepreneurs. They assist them in their development and growth, generating value for society at large. The institution offers companies a range of products and services in the area of corporate finance, focusing on loans and guarantees and venture capital investments. ICF operates via a parent company, two subsidiaries (IFEM and ICF Capital), and an investee (AVALIS). ICF, through IFEM, supports the creation and growth of innovative start-ups through the investment in venture capital funds for seed segments and co-investment with private investors through participative loans. ICF Capital, which manages closed-end UCITS and is authorized by Spain's National Securities Market Commission (CNMV), manages, nurtures, and advises public and/or private funds or venture capital firms that provide capital to Catalan companies. At present, ICF Capital directly manages 2 venture capital firms: ICF Capital Expansió II and ICF Venture Tech II.
Show more
Investment focus
- Software, Biotechnology, Health Care
- Debt Financing, Funding Round, Seed
- Spain, United States, Mexico
Portfolio highlights
- Exoticca — Exoticca develops an online platform intended to facilitate travel booking. The company's platform offers holiday packages which includes flights, accommodation, meals, guides and private transports, for exotic locations all around the world, enabling travelers to book travel packages online at competitive prices.
- Harmonix — Harmonix is a software development company that uses AI for CRM to communicate with customers to send email, calls, and SMS.
- AtG Therapeutics — At AtG, we develop new drugs and biomarkers to stop cancer metabolic adaptation.
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Equity Crowdfunding, Seed, Funding Round
- Spain, United States, United Kingdom
Portfolio highlights
- MgShell — MgShell offers intraocular devices for the treatment of age-related macular degeneration and other ocular diseases. Their technology is the only technical solution capable of replicating current clinical practice with a single injection and releasing the same therapeutic drug doses at predetermined periods, autonomously and without surgicalprocedures.
- OxyPrem — OxyPrem is a Swiss manufacturer of next-generation medical devices for oxygen-related brain monitoring of preterm infants in real time, using harmless, non-invasive near-infrared light. Our sensors continuously measure local oxygenation with the precision and accuracy that are needed to assist in clinical decision-making for these high-risk patients.
- MSInsight — Explore how our cutting-edge genomic analysis uncovers actionable insights into microsatellite instability (MSI), driving targeted, personalized cancer treatments.
Clave is an investment management company.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Funding Round, Series A
- Spain, Chile, Switzerland
Portfolio highlights
- Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
- Corify Care — CORIFY Care is a start-up funded by main world-wide experts on cardiac arrhythmias which is going to introduce in the market a novel medical device to non-invasively map cardiac arrhythmias in real time. This novel technology will improve the treatment in more than 10 million of atrial fibrillation patients only in Europe. Our non-invasiveelectro-anatomical mapping systems displays the activation patterns in each point of the heart without the need of invasive catheters, allowing the possibility to map all atrial fibrillation patients even during a regular visit to the cardiologist. CORIFY Care is located in Madrid, Spain, one of the most attractive places to work/live on the South of Europe.
- Genbioma — Evidence-based microbiome company aims to leverage the central role of probiotics and the gut microbiota on the glycemic regulation. "Microbiota" "Premium probiotics" "Long-term glycemic regulation" "Prediabetes"
Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.
Show more
Investment focus
- Biotechnology, Medical Device, Health Care
- Series A, Seed, Series B
- Spain, France, Belgium
Portfolio highlights
- Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- Spain, United States, Switzerland
Portfolio highlights
- ReproNovo — New Scientific Approaches in Reproductive Medicine. At ReproNovo, we are passionate about bringing the dream of parenthood to life.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more
Investment focus
- Biotechnology, Health Care, Medical Device
- Series A, Funding Round, Seed
- Spain, United States
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Series A, Funding Round, Seed
- Spain, Mexico
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Biocross — Biocross offers diagnostic solutions that can be used during the asymptomatic phase of the diseaseand enable early detection of individuals ..
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more
Investment focus
- Software, Biotechnology, Pharmaceutical
- Seed, Funding Round, Pre-Seed
- Spain, Portugal
Portfolio highlights
- Envita — Envita is a social innovation start-up for the development of innovative digital solutions for organizations.
- Appentra — Ensure correctness, modernization, security, and optimization for your Fortran, C, and C++ code with a powerful and efficient solution.
- Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses
Show more
Investment focus
- Software, Information Technology, Enterprise Software
- Funding Round, Seed, Series A
- Spain, United States, Mexico
Portfolio highlights
- MLCode — Accelerated by massive AI/ML adoption, Data is to become the most critical resource for Enterprises. MLCode vision is to protect that Data. MLCode: Data Security Automation.
- wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using...
- Inspiration-Q — Inspiration-Q focuses on developing and commercializing software solutions inspired by quantum computing for financial applications.
BeAble Capital is a Science Equity Fund, therefore it is a pre-seed, seed and early stage venture capital management company specialized in the identification, valuation, launch and development of technologies in the sectors of advanced materials (nanotechnology and biotechnology), photonics, micro and nano electronics and Information andcommunications technologies (ICT) platforms.It acts as the link between scientific, entrepreneurial and investing worlds to promote the transfer of technology, the creation and the development of technology-based companies (start-ups) from private equity. The company is focused on strong intelectual property and long R&D background projects. Their work provide value at different stages of development by offering support in strategic points such as the identification of technologies, valuation, transfer, companies creation, fundraising, marketing, internationalization and administrative and managerial expertise.
Show more
Investment focus
- Biotechnology, Manufacturing, Product Management
- Pre-Seed, Seed, Funding Round
- Spain, Italy
Portfolio highlights
- Reinforce 3D — Reinforce3D develops proprietary technology for reinforcing 3D-printed parts, called the continuous fiber injection process (CFIP)
- ALCYON PHOTONICS — ALCYON
- Bioinspired Materials — Bioinspired Materials is a Biotech-based entrepreneurship project with the participation of the Universitat Pompeu Fabra. The company develops wastewater valorization that produces biological products of high value in the market. BIOM was founded in 2019 and is based in Barcelona, Spain.
Moira Capital Partners is private equity firm
Show more
Investment focus
- Biotechnology, Information Technology, 3D Technology
- Funding Round, Series A, Private Equity
- Spain
Portfolio highlights
- NeuronUP — NeuronUP is a platform that provides professionals the ability to access real, when and where they want their exercise routines and their patients time manager and interact directly with their team of professionals in a specialized environment. All this generates a continuous updating of information and content platform, arising from theinter-professional dialogue.
- Voovio — Voovio's Simulation Software enables the process industry to avoid errors during SOP execution, reducing downtime & increasing safety in operations & maintenance.
- Geodesic Innovations — Geodesic Innovations is a water-saving and purification company that develops advanced water treatment, conservation, and regeneration systems to offer services for disinfection and improvement of water quality without using chemicals.
A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success.
- Investment and growth
- Specialized products and branches
- Collaborative innovation
Show more
Investment focus
- Software, Information Technology, Artificial Intelligence
- Seed, Funding Round, Pre-Seed
- Spain, Mexico, United States
Portfolio highlights
- Kloutit — Gestiona los chargebacks potenciando las defensas con IA
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
- xNova International — Find US importers with the xNova International platform in seconds. Monitor your competitors, analyze your product's demand in the US, and much more.
Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today
Show more
Investment focus
- Software, Artificial Intelligence, Machine Learning
- Series B, Seed, Series A
- United Kingdom, United States, Spain
Portfolio highlights
- Inephany — Inephany - We build systems to train AI agents specialised in optimising Neural Networks, such as LLMs and other Generative AI.
- Safe Intelligence — Safe Intelligence specializes in deep validation AI systems, focusing on enhancing the reliability of artificial intelligence models.
- iPronics — Discover the power of lossless optical switches for low latency and flexible AI architectures. Increase density and reduce power consumption with our innovative technology.
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more
Investment focus
- Biotechnology, Software, Medical
- Funding Round, Seed, Series A
- Spain, Germany, United States
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
- Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.
Developing combustion engine catalyst and coating technology to reduce emissions and improve fuel efficiency for clean energy production.
Show more
Investment focus
- Software, Information Technology, Health Care
- Funding Round, Seed, Debt Financing
- Spain, United States, Mexico
Portfolio highlights
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Atlas Molecular Pharma — Latest News Your browser does not support the video tag.
Angels Capital philosophy is to find and support at 1 able to lead a project. Their goal is to support the entrepreneurial, helping to create new businesses, help grow their business sector, generate employment and create wealth.
Show more
Investment focus
- Software, E-Commerce, Health Care
- Seed, Angel, Funding Round
- Spain, United States, Ireland
Portfolio highlights
- Internxt — Stand for privacy, switch to Internxt. Internxt's open-source cloud storage services protect your right to privacy. Internxt Drive, Photos, Send, and more.
- ODOS — Carbon Harvesters is an ag-tech start-up that increases the resilience of rural communities by facilitating cost-effective decarbonisation of the dairy sector.
- Deflores y floreros — The search for very different, exclusive and a bit daring dancers on a personal level was the reason for starting this entire project.
Gestión de Capital Riesgo del PaÃs Vasco SGECR, S.A. is a venture capital entity management company founded in 1985 by the Basque Government as part of the Sociedad para la Promoción y Reconversión Industrial (SPRI), with the aim of promoting and developing venture capital activity in the Basque Country.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Funding Round, Seed, Series A
- Spain
Portfolio highlights
- Irisbond — Irisbond creates a new way for humans to communicate through precision eye-tracking technology. Irisbond’s advanced software algorithms interpret your eye gaze in order to provide natural, intuitive and hands-free access to information and control over a screen. Developed for use in mobile devices, automotive, smart homes, robotics, scientific,healthcare and manufacturing, eye tracking technology lets you learn, play, work and communicate with your eyes. A pioneer in the assistive technology market, Irisbond’s eye tracking solutions are based on years of R&D in cooperation with Vicomtech, a leader in the field of artificial vision. For more information about the power of the eyes, go to www.irisbond.com/en
- InspectRail — InspectRail was established to offer high-quality information on the state of railway infrastructure, thereby enhancing its operation, management, and maintenance.
- Inmedical Therapeutics — Innovation in medical needs
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Seed Capital de Bizkaia is a Regional Council company affiliated to Biscay Regional Council's Department of Economic Development and Innovation (Departamento de Innovación y Promoción Económica de la Diputación Foral de Bizkaia) whose aim is to manage a Venture Capital Fund called “Seed Capital Bizkaia, F.C.R.“.
Show more
Investment focus
- Software, Biotechnology, Manufacturing
- Seed, Funding Round, Series A
- Spain, Mexico, Belgium
Portfolio highlights
- coometes — coometes offer social institutions a comprehensive solution for managing food aid and basic necessities for vulnerable persons.
- Begas Motor — Begas has designed and manufactures the first engine for industrial vehicles powered 100% by LPG (Liquefied Petroleum Gas or AUTOGAS). Ability to remotorize vehicles and make them ecological with Euro VI certificate.
- Emica Solar — Emica Solar is a company which develops the floating solar energy.
Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People
Show more
Investment focus
- Health Care, Artificial Intelligence, Biotechnology
- Pre-Seed, Funding Round, Seed
- Spain
Portfolio highlights
- Tirecat — Tirecat specialized in developing sophisticated tissue regeneration treatments to combat chronic and terminal diseases.
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
- Qilimanjaro Quantum Tech — Discover the future of computing with Qilimanjaro's analog quantum solutions, tailored for large enterprises worldwide.
Clave Capital is an independent asset management company that specializes in investment strategy.
Show more
Investment focus
- Biotechnology, Health Diagnostics, Health Care
- Seed, Funding Round
- Spain
Portfolio highlights
- MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
- Nanological — Ultra-fast Identification of Bacteria for Sepsis Diagnosis - Multiparametric characterization of mass, size and optical absorption through optical and mechanical measurements to achieve real-time direct pathogen identification.
- ADmit Therapeutics — ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer.
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Seed, Series A, Funding Round
- France, Spain, Belgium
Portfolio highlights
- Cephagenix — Cephagenix focuses on identifying and developing new, effective migraine therapies.
- Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
- Augustine Therapeutics — Augustine Therapeutics is developing selective, safe and efficacious HDAC6 inhibitors designed for treatment of neuromuscular, neurodegenerative and cardiometabolic diseases. Discover our pipeline poised for clinical impact.
APEX Ventures is an early-stage venture capital fund that invests in start-ups grounded in unique and protectable technology. They provide support and resources and aims to develop their start-ups in their respective field. Their initial focus areas include digital media, business intelligence, cybersecurity, fintech, and the future of work.
Show more
Investment focus
- Artificial Intelligence, Health Care, Software
- Seed, Series A, Pre-Seed
- Germany, United Kingdom, Austria
Portfolio highlights
- Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
- Robeaute — Redesigning the future of neurosurgery by creating the new standard device that will provide surgeons with seamless access to delicate areas of the brain parenchyma and with real-time data.
- HyperHeat — HyperHeat is a climate tech startup, that develops a breakthrough solution for zero-carbon industrial heat at very high temperatures.
Gus Bertolo
Show more
Investment focus
- Software, Biotechnology, Artificial Intelligence
- Seed
- Spain
Portfolio highlights
- Insectius — Insectius uses artificial intelligence (AI) in insect breeding, management, and manufacture of insect flour.
Our purpose is to help people and businesses prosper. We strive to make all we do Simple, Personal and Fair.
Show more
Investment focus
- Energy, Financial Services, Renewable Energy
- Debt Financing, Post-IPO Debt, Seed
- United Kingdom, Spain, United States
Portfolio highlights
- Klar — Klar is a FinTech challenger bank that provides deposit and credit services for Mexican customers.Using the Klar card rewards users with cash of up to 4% cashback for each purchase, not points without confusing conversions or expiration dates. Clients can also send and receive payments and collections money instantly to Klar accounts and otherbanks. The Klar card is linked to an app where users can see all their movements in real-time.Stefan Moller, Daniel Autrique, Jeronimo Riefkohl, and Gianluigi Davassi established the company in Mexico City, Distrito Federal in 2018.
- Tritax Big Box — Tritax Big Box is the only Real Estate Investment Trust dedicated to investing in very large logistics facilities in the UK. they own, manage and develop some of the UK’s most sought-after Big Boxes. rBig Boxes are strategically important to tenants as they offer efficiency savings and are increasingly fulfilling e-commerce retail sales.tenantsinclude some of the biggest names in retail, logistics, consumer products and automotive.they aim to provide a secure and growing income for Shareholders, together with capital appreciation. their ambition is to be the UK’s pre-eminent owner of Big Boxes.
- Clearway Energy Group — We're a leading independent clean power developer and operator with over 350 clean energy projects across America.
We identify and support the most innovative European food startups and help them to thrive in the global market
Show more
Investment focus
- Food and Beverage, Food Processing, Agriculture
- Seed, Series A
- Spain, Italy
Portfolio highlights
- Innomy — We developed a new generation of meat and take care of the planet.
- FoodSeed — FoodSeed, the national Agrifoodtech program in Italy, along with CDP Venture Capital Sgr, Fondazione Cariverona, and UniCredit.
- Foreverland — Foreverland Food is an Italian food-tech startup.
CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.
Show more
Investment focus
- Biotechnology, Health Care, Information Technology
- Seed, Funding Round, Series B
- Spain
Portfolio highlights
- Aortyx — Aortyx is a pioneer company founded by researchers from the IQS School of Engineering and the Hospital Clínic de Barcelona that aims at providing a new generation of endovascular devices to treat vascular diseases. Our technology focuses on tissue regeneration by mimicking the aorta biomechanical environment. It provides a suitable milieu for cellmigration and proliferation in a bioresorbable platform that minimizes differences with the natural dynamics of the aorta.
- Heecap — Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients.
- Geniova — Geniova is a Spanish start-up that specializes in invisible orthodontics. The company’s patented method combines the power of a lingual nickel titanium arch and conventional aligners to obtain the fastest and most predictable technique in teeth alignment. Geniova’s innovative approach to orthodontics has earned it recognition as one of the mostinnovative start-ups globally in 2021. With remarkable international potential, Geniova is poised to revolutionize the field of orthodontics.”
Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively helpfounders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies.Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.
Show more
Investment focus
- Software, Artificial Intelligence, SaaS
- Seed, Pre-Seed, Series A
- Portugal, United States, United Kingdom
Portfolio highlights
- YPLASMA — YPlasma, an INTA spin-off, develops plasma actuators for ionic flow control, enabling advancements in Energy and Electronics.
- KOA Biotech — Detecta enfermedades a tiempo y maximiza tus resultados.
- Zymvol Biomodeling — Need a new or better biocatalyst? At ZYMVOL we combine bioinformatics and molecular modeling to accelerate Enzyme Discovery and Design
> smart projects
Show more
Investment focus
- Health Care, Cooking, Medical
- Seed, Funding Round
- Spain
Portfolio highlights
- Qualityfry — If you are looking for an automatic commercial deep fryer for your business, check the QualityFry ones. Check out and request a demonstration
- Persei vivarium (Digital Health) — Persei vivarium is a digital health business dedicated to the creation of high-quality data collections that are based on real-word data for specific diseases. The technology facilitates the capture of clinical data from the physician’s daily clinicalpractice and from the patient based on a mobile appication for remote monitoring. This provides a more holistic view and better management of the disease. The information that is captured becomes a high-value resource that also, in a simple and easy process, generates high-quality research.
- Transplant Biomedicals — Diabetes can be effectively controlled by following these best tips from Diabetes Guide. You will also get to know about the tips to manage diabetes naturally
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Series A, Seed, Series B
- France, Switzerland, Spain
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Seed, Pre-Seed, Series A
- United States, Germany, United Kingdom
Portfolio highlights
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- Inductive Bio — Bringing the data, ML, software, and expertise needed to rapidly solve your most challenging ADMET problems.
- Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.
Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco. Your success is our priority, so we don’t just send some money and "check in" at board meetings. Our mission is to empower you with game-changing support throughevery stage of your journey. Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one. You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.
Show more
Investment focus
- Software, FinTech, Financial Services
- Seed, Series A, Pre-Seed
- United Kingdom, Germany, Austria
Portfolio highlights
- Mercanis — Source services smarter and drive automation along your source-to-settle process. Discover how Mercanis enables you to collaborate with best-in-class suppliers across your departments.
- ORUS — ORUS specializes in high-resolution hyperspectral spatial data and associated analytical services.
- Tibo Energy — To make sure you operate within the limits of your contract we control your network. We avoid congestion in your energy network.
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity.
Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way.
We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view.
We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money.
We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community.
We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more
Investment focus
- Life Science, Biotechnology, Medical
- Seed, Funding Round
- Spain
Portfolio highlights
- MiMARK — MiMARK focuses on improving the accuracy and efficiency of diagnostics for endometrial cancer, which is the sixth most commonly occurring cancer in women.1 As with many cancers, early and accurate detection of the disease is linked to increased survival, however currently around a third of endometrial cancer patients are diagnosed at the advancedstage.2 By improving the technology available for the diagnosis of endometrial cancer, MiMARK hopes to improve the speed and accuracy at which women can be diagnosed and effectively treated.
- Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
- OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
Grupo Ferrer International is a privately-held European R&D-based pharmaceutical company headquartered in Barcelona. It is active in the pharmaceutical, health, fine chemicals and food sectors in Europe, Latin America, Africa, the Middle East, Asia and the United States. In total, Ferrer's human health care products are commercialized inmore than 95 countries, through 24 international affiliates (including joint ventures) and 70 partners and distributors. Ferrer carries out activities throughout the full pharmaceutical value chain, from R&D to international marketing, including the fine chemical development and the manufacturing of both raw materials and finished pharmaceuticals. Its research centers in Spain and Germany, and manufacturing sites in Europe and Latin America cover the pharmaceutical, diagnostics, vaccine, fine chemical, food and feed sectors.
Show more
Investment focus
- Biotechnology, Wellness, Biopharma
- Series A, Funding Round
- Spain
Portfolio highlights
- Venter Pharma SL — Venter Pharma is a biotech company that aims to develop products in the field of gastroenterology to help patients and professionals.It arises on the bases of some research work carried out by PhD. Juan José Aragón Reyes and Alfonso Fernández Mayoralas in the Autonomous University of Madrid and Spanish National Research Council respectively.Venter Pharma focuses on the study of solutions for digestive pathologies, with especial attention to high population prevalence disorders such as lactose intolerance or inflammatory illnesses. Venter Pharma develops innovative products to make a clinical diagnosis easier, simpler and more effective. LacTEST®, is a new diagnosic drug for the diagnosis of lactose intolerance based on a new active substance: Gaxilose
- ABAC Therapeutics — ABAC Therapeutics is aimed at seeking first-in-class drugs for precision treatment of MDR Gram-negative infections. While potent pathogen-specific antibacterial activity is essential, we believe that it is necessary to incorporate early other pharmaceutical properties, such as suitable pharmacokinetics and toxicological characteristics, to maximizethe chance of success in clinical development.
Healthequity is a venture capital company specializing in early-stage projects in the health sector: medical devices, biotechnology and healthcare services. It is a fund promoted by the Official College of Physicians of Barcelona and the financial group Riva y Garcia that is looking for projects to make their first investments. Healthequity has ateam of professionals with complementary experience, with the scientific-technical and financial know-how necessary to analyze and make investments contributing value to the investee company. In addition, it has a network of contacts and key strategic relationships in the health ecosystem.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series D
- Spain, Switzerland
Portfolio highlights
- SANIFIT — A new approach to calcification disorders.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Versantis — Versantis is a Swiss pharmaceutical company, Spin-off of ETH Zurich, developing a new generation of medicines and diagnostics to revolutionize the care of patients with liver disease. Embracing lifesaving and preventive therapies, Versantis aims to answer the unmet medical need of millions of people worldwide. Its lead candidate, VS-01, iscurrently at preclinical stage and has the potential to be the first drug for acute liver disease simultaneously supporting multiple failing organs. VS-01 targets 3 rare indications and received an Orphan Drug Designation in ALF. In addition, Versantis’ pipeline promises to improve patients’ outcome in other medical fields; VS-02 and VS-03 are developed for chronic liver diseases and for the treatment of drug intoxications, both representing large market opportunities and significant upsides for Versantis.
Columbus Venture Partners is Spanish independent venture capital. It focuses on investing in early-stage opportunities in the life science industry. The firm is a team of investment professionals with a scientific, medical, and business development background combined with experience in building and investing in companies to accelerate theircommercialization.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Funding Round, Series A, Series B
- Spain, United States, United Kingdom
Portfolio highlights
- Tolerance Bio — Tolerance Bio will increase health span by preserving and restoring the function of the thymus, the master regulator of immune tolerance. Immune-mediated diseases represent a significant unmet medical challenge: cancer, autoimmunity, transplant rejection, infections, immune deficiencies, and allergi
- Artax Biopharma — Discover Artax Biopharma's pioneering Nck modulators that restore immune balance without immunosuppression. Learn more about our clinical advancements.
- Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
Archipelago Next support and promote the entrepreneurial ecosystem.
Show more
Investment focus
- Software, SaaS, Artificial Intelligence
- Seed, Funding Round, Pre-Seed
- Spain, United States
Portfolio highlights
- Ciudadela — Ciudadela is a property management company that offers digital platform for administrating and managing properties.
- Hotelverse — Hotelverse allows customers search over hotels on their platform and book rooms as per their requirements.
- Break-Event — Break-Event aids music industry professionals and businesses by transforming information into knowledge. They are dedicated to providing the product, enabling customers to make wiser decisions, and ensuring the performance of events.
Alberto Hospital Marco
Show more
Investment focus
- SaaS, Software, Logistics
- Seed
- Spain
Portfolio highlights
- Freightol — Freightol is a technological startup with the mission to digitize the transport and logistics industry. To make this industry more innovative and efficient, we used Freightol Manager, a complete digital platform that digitizes all parts of a Global Freight Forwarder: its logistical operations, handling and management of shipments, quotations,billing and customs, from the beginning to the end in real time.
- Insectius — Insectius uses artificial intelligence (AI) in insect breeding, management, and manufacture of insect flour.
Easo Ventures es una Sociedad de Capital Riesgo Vasca y Privada, cuyo objetivo es invertir en Startups y PYMES con proyectos de crecimiento.
Show more
Investment focus
- Software, Health Care, Manufacturing
- Seed, Funding Round, Series A
- Spain
Portfolio highlights
- Begas Motor — Begas has designed and manufactures the first engine for industrial vehicles powered 100% by LPG (Liquefied Petroleum Gas or AUTOGAS). Ability to remotorize vehicles and make them ecological with Euro VI certificate.
- Cloudtainer — Cloudtainer is a platform designed to improve international cargo security and traceability through blockchain technology. It offers key features such as real-time traceability, allowing users to monitor the location and status of shipments. Additionally, Cloudtainer utilizes IoT cloud locks with advanced sensors to measure internal variables liketemperature and humidity, ensuring security and transparency by securely recording every interaction with cargo for enhanced visibility.
- Opportunity Health — Self-Applicable & Life-Saving | Fast, safe, and effective in emergencies | Contact us! | Opportunity Health
BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Pre-Seed, Series A
- Canada, United States, United Kingdom
Portfolio highlights
- Xatoms — At Xatoms, we clean water with Quantum Chemistry and AI, revolutionizing water purification for communities worldwide. Our innovative approach rapidly identifies new, sustainable materials to remove harmful pollutants and pathogens. We aim to alleviate the burden on women and girls in underrepresented communities, transforming the global landscape of water accessibility and empowering a more equitable world. Xatoms is at the forefront of combining scientific innovation with social change.
- Seqera — Seqera Labs is a Barcelona-based business creating solutions for high-performance computing workloads across cloud and clusters. It was founded by the creators of the popular open-source workflow software Nextflow (http://www.nextflow.io).
- Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.
Show more
Investment focus
- Life Science, Biotechnology
- Seed
- Spain
Portfolio highlights
- OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies
BAGi is the first business angels network created for invest on Startups with direct impact on Girona's region.
Show more
Investment focus
- Internet, Health Care, Information Technology
- Seed, Angel, Funding Round
- Spain, Norway, Switzerland
Portfolio highlights
- Aniling — Aniling developing its worldwide patent of the second generation genomic analysis and epigenomic.
- Petoons Studio — Petoons Studio is a developer of transmedia projects startup.
- The Smart Lollipop — The Smart Lollipop is a non-intrusive medical device in the shape of a lollipop with the goal to detect diseases with a single saliva sample.
Fabio Núñez is an Angel Investor.
Show more
Investment focus
- Software, Biotechnology, Artificial Intelligence
- Seed
- Spain
Portfolio highlights
- Insectius — Insectius uses artificial intelligence (AI) in insect breeding, management, and manufacture of insect flour.
Kinled was founded in 1980 to retain the investment assets of the Aisher family.In 1990, the investment focus shifted to a portfolio of early stage investments applying Kinled’s company development experience alongside the endurance and passion of family owned investments together with the strategic focus of venture capitalists.Since then,Kinled has taken 8 companies to public markets and many more to successful trade sales at significant multiples.
Show more
Investment focus
- Biotechnology, Health Care, Financial Services
- Seed, Funding Round, Series A
- United Kingdom, United States, Switzerland
Portfolio highlights
- Xapien — Xapien delivers automated insight reports on companies and individuals in minutes, so you can make informed business decisions quickly and with confidence.
- OneTrust — OneTrust is a provider of privacy management and marketing compliance technology that helps organizations comply with global regulations. It automates privacy impact assessments and data inventory mapping, enforces risk remediation actions, and triggers recurring audits for continuous compliance monitoring across customer, employee, and vendor datatransfers. Its web-based software can be accessed on any device and provides a single place for a private office to collaborate with business groups, vendors, and trusted advisors managing privacy risks. The result is the ability to demonstrate privacy by design and ongoing compliance with policies, data privacy laws (GDPR, BCR, Privacy Shield), and other privacy frameworks (HITECH, ISO, GAPP, APEC).The company was founded in 2016 and is headquartered in Atlanta, Georgia.
- Connect Earth — Connect Earth is an environmental data company that builds the infrastructure for climate-conscious products by aggregating and standardising environmental data and making it available through developer-first toolkits. The core product is an API solution that calculates the carbon impact of spend-based financial transactions of consumers and companies.
Investors by industry
Consumer
Proptech
Impact
Climate
Gaming
Biotech
FinTech
Marketplace
Community
Health Care
Hardware
Energy
Artificial intelligence
Google
EdTech
Sustainability
Venture Capital
Real Estate
Photography
Clean Energy
Education
B2B
Financial Services
Big Data
Payments
Finance
Organic Food
Food and Beverage
Web3
Infrastructure
Retail
Beauty
Publishing
Video Games
Music
Art
Wellness
Franchise
Mobile
Local
Digital Media
Legal
Android
eSports
Enterprise Software
Sports
Manufacturing
Email
Medical
Social Network
Social Media
Internet
Construction
Hospitality
Platforms
Biotechnology
Cannabis
Mobile Advertising
Travel
Fitness
Recruiting
Crowdfunding
Social
Medical Device
Automotive
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Celebrity
Software
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Canada
Germany
United Kingdom
Ireland
South Korea
India
Australia
New Zealand
United States
Middle East
Brazil
LATAM
Qatar
Indonesia
Asia
Europe
Spain
South Africa
Singapore
Armenia
Saudi Arabia
Sri Lanka
China
Africa
Oceania
Japan
Vietnam
Belarus
Chile
Belgium
Hong Kong
Finland
Ghana
Georgia
Ethiopia
Gibraltar
Faroe Islands
Denmark
Egypt
Estonia
Costa Rica
Kuwait
Malta
Hungary
Morocco
Greece
Nicaragua
Barbados
Croatia
Mali
Lithuania
Belize
Bahrain
Peru
Czech Republic
Lebanon
Algeria
Jersey
Norway
Ecuador
Myanmar
Bulgaria
Mauritius
Bermuda
France
Liberia
Mexico
Poland
Malaysia
Senegal
Liechtenstein
Philippines
Sierra Leone
Italy
Tunisia
Israel
Panama
Togo
Serbia
Dominican Republic
Turkey
Nigeria
San Marino
Thailand
Iraq
Azerbaijan
Uzbekistan
Bahamas
Iceland
Taiwan
Namibia
United Arab Emirates
Sweden
Jamaica
Tanzania
Honduras
Slovenia
Bolivia
Isle of Man
El Salvador
Luxembourg
Portugal
Albania
Tajikistan
Pakistan
Ukraine
Puerto Rico
Uganda
Venezuela
Uruguay
Grenada
Jordan
Bangladesh
Zambia
Argentina
Romania
Zimbabwe
Rwanda
Russian Federation
Kazakhstan
Kenya
Cayman Islands
Cambodia
Cameroon
Latvia
Cyprus
Oman
Austria
Switzerland
Seychelles
Colombia
Guatemala
Marshall Islands
Investors in Spain by industry
Crowdfunding
Film
Financial Services
Venture Capital
Transportation
Cryptocurrency
Finance
Payments
Food and Beverage
Organic Food
Video Games
Wine And Spirits
Web3
Medical
CleanTech
Wellness
Medical Device
Social Media
Internet
Digital Media
Manufacturing
Art
Music
Android
Blockchain
Mobile
Local
Software
Legal
Construction
eSports
Enterprise Software
Sports
Fitness
Hospitality
Automotive
Travel
InsurTech
Recruiting
Mobile Advertising
Platforms
Biotechnology
FinTech
Consumer
Health Care
Biotech
Energy
Climate
EdTech
Sustainability
Impact
Restaurants
Marketplace
Retail
Hardware
Gaming
Social
Fashion
Beauty
B2B
Life Science
Publishing
Education
Oil and Gas
Clean Energy
Renewable Energy
SaaS
Enterprise
Infrastructure
Mobile Apps
Big Data
Sporting Goods
Social Network
Photography
Social Impact
Artificial intelligence
Real Estate
Media (entertainment)
Agriculture (agtech)
Machine Learning
Proptech
Community